Allakos Funding & Investors
Allakos Inc. operates as a clinical stage bio-technology company. The Company discovers and develops therapeutic antibodies for the treatment of allergic, inflammatory, and proliferative diseases. Allakos serves customers in the United States.
allakos.comTotal Amount Raised: $284,500,000
Allakos Funding Rounds
Post Ipo Equity
$150,000,000
Post Ipo Equity Investors
Commodore CapitalVivo CapitalBraidwellRTW InvestmentsDeep Track CapitalNew Enterprise Associates (NEA)Logos CapitalTCG Crossover ManagementFrazier Life SciencesBiotechnology Value FundSurveyor CapitalAlta PartnersSeries B
$100,000,000
Series B Investors
New Enterprise Associates (NEA)RiverVestPartner Fund Management3x5 PartnersRoche Venture FundRock Springs CapitalAlta PartnersRedmile GroupSamsara BioCapitalLifeSci Venture PartnersSeries A
$10,000,000
Series A Investors
Novo VenturesAlta PartnersRiverVestRoche Venture FundSeries A
$24,500,000
Series A Investors
Alta PartnersRiverVestNovo VenturesRoche Venture Fund
Funding info provided by Diffbot.